Immunotherapy With Nivolumab (Opdivo) Can Lower Recurrence When Bladder Cancer Spreads

MONDAY, May 16, 2022 -- Immunotherapy with nivolumab (Opdivo) after surgery for metastatic bladder cancer significantly reduces the odds for the tumor's return, a new clinical trial finds.

Among 700 patients with urothelial cancer of the bladder or...